文献速递传染病防控与疫情报告

嵌合蛋白rFhLAP-CL1对绵羊肝片形吸虫攻毒诱导中等保护

Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
PubMed 文献 · Vaccine · 2019-04-26

该研究将肝片形吸虫亮氨酸氨肽酶(FhLAP)与组织蛋白酶L1(FhCL1)的抗原序列构建为嵌合蛋白rFhLAP-CL1,在绵羊中评价其免疫保护效果。25只绵羊随机分为5组,分别以100、200、400 μg嵌合蛋白加Quil A佐剂免疫两次,佐剂对照和感染对照各一组,随后以200个囊蚴攻毒。结果显示虫负荷分别降低25.5%、30.7%(p<0.05)和46.5%(p<0.01),粪卵数在200 μg和400 μg组分别降低22.7%(p<0.05)和24.4%(p<0.01),并诱导混合Th1/Th2抗体反应。

要点

  • rFhLAP-CL1嵌合蛋白在绵羊中诱导对肝片形吸虫的部分保护。
  • 400 μg剂量组虫负荷降低46.5%(p<0.01),为所试剂量中最高。
  • 200 μg和400 μg组粪卵数分别降低22.7%和24.4%。

核心结论

  • 嵌合蛋白rFhLAP-CL1在绵羊中诱导中等程度的抗肝片形吸虫保护,表现为虫负荷和粪卵数下降。

研究设计与样本

  • 绵羊随机分为5组,每组5只;3组分别以100、200、400 μg rFhLAP-CL1加Quil A佐剂免疫两次,另设佐剂对照和感染对照。
  • 免疫后两周以200个肝片形吸虫囊蚴攻毒,评估虫负荷、粪卵数和抗体反应。

主要发现

  • 与感染对照组相比,100、200、400 μg免疫组虫负荷分别降低25.5%、30.7%(p<0.05)和46.5%(p<0.01)。
  • 200 μg和400 μg组粪卵数分别降低22.7%(p<0.05)和24.4%(p<0.01)。
  • 免疫羊产生F. hepatica排泄-分泌产物特异性总IgG抗体,攻毒后升高;rFhLAP-CL1特异性IgG1和IgG2在首次免疫后两周快速升高,显著高于对照组,提示混合Th1/Th2反应。

局限性

  • 本研究为rFhLAP-CL1作为绵羊肝片形吸虫感染候选免疫原的初步评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Leucine aminopeptidase (FhLAP) and cathepsin L1 (FhCL1) of Fasciola hepatica play a critical role in parasite feeding, migration through host tissue, and immune evasion. These antigens have been tested for immune protection as single components with variable degrees of success. The chimeric-protein approach could improve protection levels against fasciolosis. Previously, we reported the design and construction of a chimeric protein composed of antigenic sequences of FhLAP and FhCL1 of F. hepatica. The goal of the present study was to express and evaluate the immune-protective capacity of this chimeric protein (rFhLAP-CL1) in sheep. Animals were randomly allocated into five groups with five animals in each group. Groups 1, 2 and 3 were immunized twice with 100 μg, 200 μg and 400 μg of rFhLAP-CL1 emulsified with Quil A adjuvant, whereas groups 4 and 5 were the adjuvant control and infection control groups, respectively. The animals were then challenged with 200 metacercariae two weeks after the rFhLAP-CL1 booster. The fluke burden was reduced by 25.5%, 30.7% (p < 0.05) and 46.5% (p < 0.01) in sheep immunized with 100 μg, 200 μg and 400 μg of chimeric protein, respectively, in comparison to the infection control group. There was a reduction of 22.7% (p < 0.05) and 24.4% (p < 0.01) in fecal egg count in groups 2 and 3, respectively, compared to the infection control group. Sheep immunized with chimeric protein produced F. hepatica excretion-secretion product-specific total IgG antibody, which were increased after challenge. Moreover, the levels of rFhLAP-CL1-specific IgG1 and IgG2 isotypes in immunized sheep increased rapidly two weeks after the first immunization and were significantly more elevated than those of the control groups, indicating a mixed Th1/Th2 response. This is a preliminary evaluation of the chimeric protein rFhLAP-CL1 as a possible immunogen against F. hepatica infection in sheep.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ortega-Vargas S, Espitia C, Sahagún-Ruiz A, et al. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep. Vaccine. 2019. PMID: 31036453. doi:10.1016/j.vaccine.2019.04.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。